PrimeRFP SCOUT · Federal Contract Profile

Inhalon Biopharma (HFQSJ2GMNRU6)Federal contracts · 2 recompetes

Inhalon Biopharma holds $5.4M in federal volume across 2 award actions, with 100% at Department of Defense (DOD). SCOUT tracks 2 incumbent recompetes — an estimated $5.4M returning to market over the next 24 months (Moderate exposure). Primary work: Research And Development In The (100% prime). Obligations are up 42% year over year.

$5.4M
Federal Volume
2
Recompetes (24mo)
DOD
Top Agency · 100% firm-wide
2
Award Actions

Choose one — this changes what we ask next

Score my firm against Inhalon Biopharma

Email me when a Inhalon Biopharma recompete window opens.

Data through · refreshed monthly · window Aug 2025 – Aug 2026

Why are you looking at Inhalon Biopharma?

Score my firm against Inhalon Biopharma

Email me when a Inhalon Biopharma recompete window opens.

What they do

Capability

Service lines

RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)

Work mix: 100% prime · 0% sub · primary NAICS 541715 / PSC AN13 HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT

Where they win

Sole agency
Sole agency: Department of Defense (DOD)

Recompete exposure: Moderate · 2 in 24mo

Inhalon Biopharma has an estimated $5.4M in contracts returning to market over the next 24 months.

Who buys from them

Agency buyer map

1 buyers
With competitive federal procurements, winning starts with strategically understanding the customer environment to the left of SAM.gov. This is what SCOUT does - a deeper and more precise understanding of what the…
Peter Lierni, Solutioneering
Explore another company
Don’t see your company?

Enter your company name and we'll build the page.

Query this company live in SCOUT via MCP — personalized displacement scoring, alerts, and capture workflow. Learn about SCOUT MCP →

Frequently asked questions

What federal contracts does Inhalon Biopharma hold?

Inhalon Biopharma (UEI HFQSJ2GMNRU6) shows $5.4M across 2 award actions in SCOUT’s public USASpending-backed profile, with Department of Defense (DOD) as the top buying agency. Totals cover federal prime awards ≥$100K in the rolling window.

How much in federal contracts does Inhalon Biopharma have?

Inhalon Biopharma shows $5.4M across 2 award actions. SCOUT tracks 2 incumbent recompetes ($5.4M) returning to market in the next 24 months.

Which agencies does Inhalon Biopharma work with?

Inhalon Biopharma’s firm-wide obligated mix is led by Department of Defense (DOD) (100%).

What is the UEI for Inhalon Biopharma?

The Unique Entity ID (UEI) for Inhalon Biopharma is HFQSJ2GMNRU6.

Does Inhalon Biopharma have contracts coming up for recompete?

Yes — SCOUT tracks 2 incumbent recompetes in the next 24 months (Moderate exposure). Open the recompete section on this page for PIID-level timing.

Seen enough? Run one full capture cycle on Inhalon Biopharma — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Sources: USASpending, FPDS, SAM.gov · Data shown is public-record; analysis by PrimeRFP SCOUT. Corpus refreshed Aug 20, 2026. Profile snapshot Aug 19, 2026.
primerfp.com/intel/company/inhalon-biopharma-inc